EIP
NVLN

Easterly Investment Partners’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

Easterly Investment Partners’s Portfolio NVLN Stock Details NVLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-18,484
Closed -$13K – 101
2019
Q3 		$13K Hold
18,484
– – ﹤0.01% 86
2019
Q2 		$14K Hold
18,484
– – ﹤0.01% 89
2019
Q1 		$23K Buy
+18,484
New +$21K ﹤0.01% 87

Other funds holding NVLN

SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
FSA
Franklin Street Advisors Chapel Hill, North Carolina $1.79B AUM 28.1% 1-Year Est. Return

Easterly Investment Partners's NVLN Position: Q4 2019 in Review

Easterly Investment Partners sold out of Novelion Therapeutics Inc. Common Shares (NVLN) in Q4 2019, closing a stake of 18,484 shares — an estimated $13K sold.

Easterly Investment Partners first reported a position in NVLN in Q1 2019 and held it in 3 quarters. The position peaked at $23K in Q1 2019. 7 funds tracked by Wall St. Rank hold NVLN as of Q4 2019.

  • Easterly Investment Partners reported no remaining Novelion Therapeutics Inc. Common Shares position as of Q4 2019 after selling out during the quarter.
  • Easterly Investment Partners sold 18,484 Novelion Therapeutics Inc. Common Shares shares in Q4 2019, an estimated $13K.
  • Easterly Investment Partners first reported a position in Novelion Therapeutics Inc. Common Shares in Q1 2019 and held it in 3 quarters.
  • Easterly Investment Partners's Novelion Therapeutics Inc. Common Shares position peaked at $23K in Q1 2019.
  • 7 funds tracked by Wall St. Rank held Novelion Therapeutics Inc. Common Shares as of Q4 2019.

Based on Easterly Investment Partners's 13F filing for Q4 2019, filed 11 Feb 2020.